Evidence map›Paper›PMID 39596758›Full record

ArticleAntibiotics (Basel, Switzerland)2024

Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections.

Giustino Parruti, Ennio Polilli, Simona Coladonato, Giorgia Rapacchiale, Francesca Trave, Elena Mazzotta, Martina Bondanese, Francesco Di Masi, Davide Recinelli, Serena Corridoni and 4 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Giustino ParrutiInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.ORCID 0000-0003-3483-8170
Ennio PolilliClinical Pathology, Santo Spirito General Hospital, 65124 Pescara, Italy.ORCID 0000-0003-4850-5182
Simona ColadonatoInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.ORCID 0009-0006-2850-2848
Giorgia RapacchialeInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Francesca TraveInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Elena MazzottaInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Martina BondaneseInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Francesco Di MasiInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Davide RecinelliInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Serena CorridoniPharmacy Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Alberto CostantiniPharmacy Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Stefano IannirubertoInfectious Disease Unit, Santo Spirito General Hospital, 65124 Pescara, Italy.
Pierluigi CacciatoreInternal Medicine Day Hospital, Santo Spirito General Hospital, 65124 Pescara, Italy.
Fabrizio CarinciDepartment of Statistical Sciences, University of Bologna, 40126 Bologna, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic therapydalbavancinGram-positive infectionsinfectionstolerability

Identifiers

PMID39596758
PMCPMC11591112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.